Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FangzhouHKSE:06086 +0.68%11 EV-to-FCF is 7.43 as of Sep. 10, 2026, which is 96% below its 10-year median of 196.80. GuruFocus rates HKSE:06086 with a GF Score™ of 11/100. The stock has 3 warning signs investors should review. Among 422 Healthcare Providers & Services companies, Fangzhou ranks better than 78.44% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Fangzhou's Enterprise Value is HK$549 Mil.
Fangzhou's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$74 Mil. Therefore, Fangzhou's EV-to-FCF for today is 7.43.
The historical rank and industry rank for Fangzhou's EV-to-FCF or its related term are showing as below:
HKSE:06086'
s EV-to-FCF Range Over the Past 10 Years
Min: 7.43 Med: 196.8 Max: 543
Current: 7.99
During the past 5 years, the highest EV-to-FCF of Fangzhou was 543.00. The lowest was 7.43. And the median was 196.80.
HKSE:06086's EV-to-FCF is ranked better than 78.44% of 422
companies
in the Healthcare Providers & Services industry
Industry Median: 17.38
vs HKSE:06086: 7.99
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Fangzhou's share price for today is HK$0.735.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Fangzhou's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.012.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Fangzhou EV-to-FCF Related Terms
Fangzhou EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Fangzhou's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Fangzhou's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fangzhou EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fangzhou's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Fangzhou's EV-to-FCF falls into.
Fangzhou's current Enterprise Value is HK$549 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Fangzhou's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$74 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fangzhou (HKSE:06086) has a EV-to-FCF of 7.43 as of Sep. 10, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Fangzhou and its competitors. This is 96% below median its historical median of 196.80. Over the past decade, Fangzhou's EV-to-FCF has ranged from 7.43 to 543.00. According to the industry distribution chart, Fangzhou ranks #91 out of 422 companies in the Healthcare Providers & Services industry, placing it in the top 21.6%.
Is Fangzhou's EV-to-FCF too high?
Fangzhou's current EV-to-FCF of 7.43 is 96% below median its 10-year median of 196.80. Over the past 10 years, this metric has ranged from a low of 7.43 to a high of 543.00. The Healthcare Providers & Services industry median EV-to-FCF is 17.38. Fangzhou's value of 7.43 is 57.2% below this industry median. Based on the distribution chart, Fangzhou ranks #91 out of 422 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Fangzhou has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Fangzhou's EV-to-FCF compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Fangzhou ranks #91 out of 422 companies for EV-to-FCF. This places Fangzhou in the top 22% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 17.38. Fangzhou's value of 7.43 is 57.2% below this benchmark. Historically, Fangzhou's own EV-to-FCF has ranged from 7.43 to 543.00 over the past decade. While the company's 10-year median is 196.80 vs. the industry median of 17.38, Fangzhou has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.38, based on 422 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fangzhou's current EV-to-FCF of 7.43 is 57.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Fangzhou and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fangzhou's current EV-to-FCF is 7.43, which is 96% below median its own 10-year median of 196.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fangzhou stock overvalued right now?
Fangzhou (HKSE:06086) has a current EV-to-FCF of 7.43. The current EV-to-FCF is 7.43, which is 96% below median its 10-year median of 196.80 and 57.2% below the Healthcare Providers & Services industry median of 17.38. Fangzhou's overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Fangzhou (HKSE:06086), the current EV-to-FCF is 7.43 as of Sep. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Fangzhou Inc is a online chronic disease management platform in China. It has focus on chronic disease management to address the needs of patients with chronic diseases, such as hypertension, cardiovascular and respiratory chronic diseases. The company provide comprehensive medical services and online retail pharmacy services through Jianke Platform. The principal segment of the group are online retail pharmacy services, comprehensive medical services, Wholesale and customized content and marketing solutions. Key revenue is generated from Online retail pharmacy services.
11GF Score
Get the complete analysis for HKSE:06086
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06086 has been successfully added to your 
